Glycyrrhizin and boswellic acids, the golden nutraceuticals: multitargeting for treatment of mild–moderate COVID-19 and prevention of post-COVID cognitive impairment

Breakthrough infections have been reported in fully vaccinated persons. Furthermore, rebound symptoms have been reported following the new FDA granted emergency use to combat SARS-CoV-2. Glycyrrhizin (GR) and boswellic acids (BAs) combination has been shown to have highly successful actions against...

Descripción completa

Detalles Bibliográficos
Autores principales: Gomaa, Adel A., Abdel-Wadood, Yasmin A., Gomaa, Mohamed A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9493173/
https://www.ncbi.nlm.nih.gov/pubmed/36136251
http://dx.doi.org/10.1007/s10787-022-01062-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9493173/
https://www.ncbi.nlm.nih.gov/pubmed/36136251
http://dx.doi.org/10.1007/s10787-022-01062-3

Ejemplares similares